GSK wins WHO seal of approval for malaria vaccine
![Photo: Dado Ruvic/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14381378.ece/ALTERNATES/schema-16_9/20220718-083058-2-4000x2247ma.jpg)
The World Health Organization (WHO) has prequalified a vaccine against malaria for the first time ever – Mosquirix, developed by British GSK, can now be procured, the British company announces in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
GSK to invest USD 1.2bn in infectious disease battle
For subscribers